Institutional investors purchased a net $192.8 thousand shares of CYCC during the quarter ended June 2014, and now own 13.15% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
THE CALIFORNIA PUBLIC EMPLOYEES ... Bought 90.7 Thousand shares of Cyclacel Pharmaceuticals ...
THE VANGUARD GROUP, INC. Bought 36.0 Thousand shares of Cyclacel Pharmaceuticals ...